Axsome Therapeutics Announces First Patient Enrolled in Phase 2 Clinical Trial of AXS-05 in Smoking Cessation

NEXT STORY
Summit Highlights Discovery of New Mechanism Antibiotics for the Treatment of Gonorrhoea at ECCMID 2018
PREV STORY
BriaCell Activates A Clinical Site in Florida for Phase IIa Study of its Lead Candidate in Advanced Breast Cancer
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents

author_avatar
NASDAQ Market News

Nova Scotia Exports Mental Health Resources

HALIFAX, Nova Scotia, June 06, 2018 (GLOBE NEWSWIRE) -- Two evidence-based mental health resources ...

author_avatar
NASDAQ Market News

Global Rapid Diagnostics Market Outlook and Forecast Report 2020-2025 Featuring Prominent Players – Abbott, Hoffmann-La Roche & Siemens Healthineers

author_avatar
NASDAQ Market News